Skip to content
10-K

Annual Report

ANAVEX LIFE SCIENCES CORP. AVXL

0001731122-25-001596

← back to feed
Filed
Nov 25, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Nov 24, 2025 89.35M sh
Shares Diluted FY 2025 · Sep 30, 2025 85.29M sh
Shares Diluted FY 2025 · Sep 30, 2024 83.47M sh
Shares Diluted FY 2025 · Sep 30, 2023 79.79M sh
Operating Cash Flow FY 2025 · Sep 30, 2025 −$39.04M
Operating Cash Flow FY 2025 · Sep 30, 2024 −$30.81M
Operating Cash Flow FY 2025 · Sep 30, 2023 −$27.79M
Cash And Equivalents FY 2025 · Sep 30, 2025 $102.58M
Cash And Equivalents FY 2025 · Sep 30, 2024 $132.19M
Stockholders Equity FY 2025 · Sep 30, 2025 $94.87M
Stockholders Equity FY 2025 · Sep 30, 2024 $120.26M
Stockholders Equity FY 2025 · Sep 30, 2023 $141.85M
Stockholders Equity restated FY 2025 · Sep 30, 2022 $142.49M
Total Liabilities FY 2025 · Sep 30, 2025 $8.95M
Total Liabilities FY 2025 · Sep 30, 2024 $15.3M
Total Assets FY 2025 · Sep 30, 2025 $103.82M
Total Assets FY 2025 · Sep 30, 2024 $135.57M
Eps Diluted FY 2025 · Sep 30, 2025 −$0.54
Eps Diluted FY 2025 · Sep 30, 2024 −$0.52
Eps Diluted FY 2025 · Sep 30, 2023 −$0.60
Eps Basic FY 2025 · Sep 30, 2025 −$0.54
Eps Basic FY 2025 · Sep 30, 2024 −$0.52
Eps Basic FY 2025 · Sep 30, 2023 −$0.60
Sga Expense FY 2025 · Sep 30, 2025 $13.82M
Sga Expense FY 2025 · Sep 30, 2024 $11.04M
Sga Expense FY 2025 · Sep 30, 2023 $12.05M
Rd Expense FY 2025 · Sep 30, 2025 $37.59M
Rd Expense FY 2025 · Sep 30, 2024 $41.84M
Rd Expense FY 2025 · Sep 30, 2023 $43.72M
Net Income FY 2025 · Sep 30, 2025 −$46.38M
Net Income FY 2025 · Sep 30, 2024 −$43M
Net Income FY 2025 · Sep 30, 2023 −$47.51M
Operating Income FY 2025 · Sep 30, 2025 −$51.41M
Operating Income FY 2025 · Sep 30, 2024 −$52.88M
Operating Income restated FY 2025 · Sep 30, 2023 −$55.76M